147 related articles for article (PubMed ID: 6097199)
1. Identical binding properties of (+/-)- and (-)-125Iodocyanopindolol to beta 2-adrenoceptors in intact human lymphocytes.
O'Hara N; Brodde OE
Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):24-39. PubMed ID: 6097199
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of beta 1-adrenergic receptors in human placenta by (-)[125I]iodocyanopindolol binding.
Paci A; Cocci F; Piras F; Niedermeyer HP; Matteucci E; Vitali C; Ciarimboli G; Bombardieri S
J Nucl Med Allied Sci; 1989; 33(1):15-21. PubMed ID: 2545844
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterisation of beta-adrenoceptors on intact equine peripheral blood lymphocytes with the radioligand (-)-[125I]-iodocyanopindolol.
Abraham G; Broddet OE; Ungemach FR
Equine Vet J; 2001 Sep; 33(5):487-93. PubMed ID: 11558744
[TBL] [Abstract][Full Text] [Related]
4. Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
Marsh JD; Smith TW
Mol Pharmacol; 1985 Jan; 27(1):10-8. PubMed ID: 2981398
[TBL] [Abstract][Full Text] [Related]
5. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.
Bjørnerheim R; Golf S; Hansson V
Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020
[TBL] [Abstract][Full Text] [Related]
6. Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.
Sillence MN; Moore NG; Pegg GG; Lindsay DB
Br J Pharmacol; 1993 Aug; 109(4):1157-63. PubMed ID: 8104645
[TBL] [Abstract][Full Text] [Related]
7. Receptor-independent sequestration of beta-adrenergic ligands by alveolar type II cells.
Fabisiak JP; Rannels SR; Vesell ES; Rannels DE
Am J Physiol; 1986 Jun; 250(6 Pt 1):C871-9. PubMed ID: 3013016
[TBL] [Abstract][Full Text] [Related]
8. Binding of 125I-cyanopindolol to beta-1-adrenoceptors in a high and low affinity state.
Hoyer D; Engel G
J Recept Res; 1983; 3(1-2):45-59. PubMed ID: 6304308
[TBL] [Abstract][Full Text] [Related]
9. Identification of a homogeneous class of beta 2-adrenoceptors in human platelets by (-)-125I-iodopindolol binding.
Wang XL; Brodde OE
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(5):439-50. PubMed ID: 2866204
[TBL] [Abstract][Full Text] [Related]
10. Application of [125I]iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat.
Offord SJ; Ordway GA; Frazer A
J Pharmacol Exp Ther; 1988 Jan; 244(1):144-53. PubMed ID: 3335996
[TBL] [Abstract][Full Text] [Related]
11. Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.
Sillence MN; Matthews ML
Br J Pharmacol; 1994 Mar; 111(3):866-72. PubMed ID: 7912629
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological characterization of chicken cardiac beta-adrenoceptors].
Nakao Y
Hokkaido Igaku Zasshi; 1987 Sep; 62(5):737-48. PubMed ID: 2891597
[TBL] [Abstract][Full Text] [Related]
13. Acute regulation of lymphocyte beta 2-adrenoceptors is altered in patients with essential hypertension.
Brodde OE; Daul AE; O'Hara N; Wang XL; Bock KD
J Hypertens Suppl; 1985 Dec; 3(3):S149-52. PubMed ID: 2856815
[TBL] [Abstract][Full Text] [Related]
14. Homogeneous class of beta-1 adrenergic receptors in rat kidney. Identification by (+/-)-125 iodocyanopindolol binding.
Brodde OE
Biochem Pharmacol; 1982 May; 31(9):1743-7. PubMed ID: 6285932
[TBL] [Abstract][Full Text] [Related]
15. Characterization of rat cerebral cortical beta adrenoceptor subtypes using (-)-[125I]-iodocyanopindolol.
Tiong AH; Richardson JS
J Recept Res; 1989-1990; 9(6):495-508. PubMed ID: 2577008
[TBL] [Abstract][Full Text] [Related]
16. (+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig.
Engel G; Hoyer D; Berthold R; Wagner H
Naunyn Schmiedebergs Arch Pharmacol; 1981; 317(4):277-85. PubMed ID: 6119625
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte beta 2-adrenoceptors mirror precisely beta 2-adrenoceptor, but poorly beta 1-adrenoceptor changes in the human heart.
Michel MC; Beckeringh JJ; Ikezono K; Kretsch R; Brodde OE
J Hypertens Suppl; 1986 Dec; 4(6):S215-8. PubMed ID: 2886571
[TBL] [Abstract][Full Text] [Related]
18. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
Sawutz DG; Sylvestre D; Homcy CJ
J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414
[TBL] [Abstract][Full Text] [Related]
19. Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding.
Williams LT; Snyderman R; Lefkowitz RJ
J Clin Invest; 1976 Jan; 57(1):149-55. PubMed ID: 1245597
[TBL] [Abstract][Full Text] [Related]
20. Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues.
Goretzki PE; Wahl RA; Branscheid D; Roeher HD
Surgery; 1984 Dec; 96(6):1001-8. PubMed ID: 6150553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
